Electronic Health Intervention for Childhood Leukemia
Trial Summary
What is the purpose of this trial?
This clinical trial evaluates a high intensity electronic health (eHealth) intervention program for reducing learning disparities in children with cancer. Most children with leukemia and lymphoblastic lymphoma can be cured due to advancements in diagnosis and treatment. However, because treatments for these conditions target the central nervous system, these children are at increased risk for developing neurocognitive late effects (problems with attention, thinking, learning, and remembering). Fortunately, many survivors do well, but some children continue to struggle with learning and have academic difficulties after their cancer treatments. The purpose of this research study is to see whether providing parents with educational knowledge and parenting tips using videoconferencing and a special website better helps their cancer survivor child in learning and school achievement compared to typical services.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications. It seems focused on educational support rather than medical treatment, so you may not need to change your medications.
What data supports the effectiveness of the High Intensity Electronic Health Intervention for childhood leukemia?
Research on eHealth (electronic health) and mHealth (mobile health) interventions in pediatric cancer shows that these technologies can improve communication between patients and healthcare providers, reduce distress, and enhance quality of life. Although specific data on the High Intensity Electronic Health Intervention for childhood leukemia is not available, similar interventions have shown promise in improving care for pediatric cancer patients.12345
Is the Electronic Health Intervention for Childhood Leukemia safe for humans?
The research articles do not provide specific safety data for the Electronic Health Intervention for Childhood Leukemia or similar interventions. They focus on adverse events related to chemotherapy and electronic health record usability, not on the safety of the electronic health intervention itself.26789
How is the High Intensity Electronic Health Intervention treatment for childhood leukemia different from other treatments?
The High Intensity Electronic Health Intervention is unique because it uses electronic health records (EHR) and web-based systems to enhance treatment protocols and patient management, offering remote access and data validation, which is not a standard feature in traditional treatments for childhood leukemia.25101112
Research Team
Sunita K. Patel
Principal Investigator
City of Hope Medical Center
Eligibility Criteria
This trial is for English or Spanish-speaking parents of children aged 6-12 who have been treated for acute leukemia or lymphoblastic lymphoma, are in remission, and enrolled in school. The child should understand English and be able to comply with study procedures. Children with severe neurodevelopmental disorders or extensive prior use of the IXL program, as well as those involved in similar studies, cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline
Pre-study
Parent-child dyads attend 4 intervention sessions over 10 weeks and provide feedback in support of intervention refinement.
Treatment
Patients and parents undergo high intensity eHealth intervention through the interactive website and via videoconferencing for 30-50 minutes once every 3 to 4 weeks for up to 5 sessions over 6 months.
Booster Sessions
Parents attend booster sessions at months 7, 9, and 11.
Follow-up
Participants are monitored for learning and school-related outcomes up to 12 months post-enrollment.
Treatment Details
Interventions
- High Intensity Electronic Health Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
City of Hope Medical Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator